MedPath

Potassium citrate

Generic Name
Potassium citrate
Brand Names
Cytra-K, Urocit-K
Drug Type
Small Molecule
Chemical Formula
C6H5K3O7
CAS Number
866-84-2
Unique Ingredient Identifier
86R1NVR0HW
Background

Potassium citrate (also known as tripotassium citrate) is a potassium salt of citric acid. It is a white, hygroscopic crystalline powder. It is odorless with a saline taste. It contains 38.3% potassium by mass. In the monohydrate form it is highly hygroscopic and deliquescent.

Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. Potassium Citrate is indicated also for the management of Hypocitraturic calcium oxalate nephrolithiasis.

Indication

For the management of renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.

Associated Conditions
Bowel preparation therapy, Constipation, Hypocitraturic calcium oxalate nephrolithiasis, Kidney Stones, Metabolic Acidosis, Renal tubular acidosis, Uremia, Uric Acid Nephrolithiasis, Chronic metabolic acidosis
Associated Therapies
Laxative

Impact of Sodium Bicarbonate on 24-hour Urine Parameters in Hypocitriuric and Uric Acid Stone Formers

Phase 1
Not yet recruiting
Conditions
Uric Acid Stones
Interventions
First Posted Date
2024-03-28
Last Posted Date
2025-01-27
Lead Sponsor
University of California, Irvine
Target Recruit Count
100
Registration Number
NCT06335537
Locations
🇺🇸

University of California, Irvine Medical Center, Orange, California, United States

Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones

Phase 4
Recruiting
Conditions
Calcium Phosphate Kidney Stones
Interventions
Dietary Supplement: OHCit- low dose
Drug: Placebo
Dietary Supplement: OHCit- standard dose
First Posted Date
2023-08-21
Last Posted Date
2025-04-06
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
25
Registration Number
NCT06003348
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

Potassium Citrate and Crystal Light Lemonade

Not Applicable
Recruiting
Conditions
Kidney Stone
Interventions
First Posted Date
2022-05-25
Last Posted Date
2025-04-27
Lead Sponsor
Northwestern University
Target Recruit Count
10
Registration Number
NCT05389995
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet

Early Phase 1
Not yet recruiting
Conditions
Kidney Stone
Interventions
Dietary Supplement: Litholyte
Dietary Supplement: Crystal Lite
First Posted Date
2020-12-03
Last Posted Date
2025-05-09
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
15
Registration Number
NCT04651088
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Study Evaluating Patients With Cystinuria and Efficacy and Safety Exploratory Study in the Youngest Children

Phase 2
Not yet recruiting
Conditions
Cystinuria
Interventions
Drug: Placebo
First Posted Date
2019-11-01
Last Posted Date
2023-05-09
Lead Sponsor
Advicenne Pharma
Target Recruit Count
72
Registration Number
NCT04147871
Locations
🇫🇷

CHU Grenoble, Grenoble Cedex, France

🇫🇷

Centre Hospitalier Universitaire de Lyon - Hôpital Femme Mère Enfant, Bron, France

🇫🇷

CHU Purpan, Toulouse cedex 9, France

and more 9 locations

Study Evaluating Patients With Cystinuria

Phase 2
Withdrawn
Conditions
Cystinuria
Interventions
Drug: Standard of Care
First Posted Date
2019-10-24
Last Posted Date
2024-03-12
Lead Sponsor
Advicenne Pharma
Registration Number
NCT04137978
Locations
🇫🇷

CHU Reims, Reims, France

🇧🇪

UZ Leuven, Gasthuisberg Hospital, Leuven, Belgium

🇫🇷

CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France

and more 10 locations

Extension Study in Primary Distal Renal Tubular Acidosis

Phase 3
Withdrawn
Conditions
Acidosis, Renal Tubular
Interventions
First Posted Date
2019-02-05
Last Posted Date
2024-03-12
Lead Sponsor
Advicenne Pharma
Registration Number
NCT03831152
Locations
🇺🇸

University of South Florida Pediatric Infectious Diseases, Tampa, Florida, United States

Dietary Counseling or Potassium Supplement to Increase Potassium Intake in Patients With High Blood Pressure

Phase 3
Completed
Conditions
Hypertension
Interventions
Behavioral: Dietary Counselling
First Posted Date
2019-01-18
Last Posted Date
2025-04-09
Lead Sponsor
Ottawa Hospital Research Institute
Target Recruit Count
7
Registration Number
NCT03809884
Locations
🇨🇦

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Study Evaluating Subjects With Distal Renal Tubular Acidosis

Phase 3
Terminated
Conditions
Distal Renal Tubular Acidosis
Interventions
Drug: Placebo
First Posted Date
2018-08-23
Last Posted Date
2024-03-22
Lead Sponsor
Advicenne Pharma
Target Recruit Count
3
Registration Number
NCT03644706
Locations
🇺🇸

The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

🇺🇸

Children's Hospital Colorado, Aurora, Colorado, United States

and more 5 locations

Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature

Phase 3
Conditions
Nephrocalcinosis
Interventions
First Posted Date
2012-12-27
Last Posted Date
2012-12-27
Lead Sponsor
Juan A. Arnaiz
Target Recruit Count
74
Registration Number
NCT01756547
Locations
🇪🇸

Hospital Clínic de Barcelona, Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath